LADCX
Price
$9.88
Change
+$0.10 (+1.02%)
Updated
Jul 17 closing price
Net Assets
1.92B
VSGIX
Price
$78.86
Change
+$0.63 (+0.81%)
Updated
Jul 16 closing price
Net Assets
36.92B
Interact to see
Advertisement

LADCX vs VSGIX

Header iconLADCX vs VSGIX Comparison
Open Charts LADCX vs VSGIXBanner chart's image
Lord Abbett Developing Growth C
Price$9.88
Change+$0.10 (+1.02%)
VolumeN/A
Net Assets1.92B
Vanguard Small Cap Growth Index I
Price$78.86
Change+$0.63 (+0.81%)
VolumeN/A
Net Assets36.92B
LADCX vs VSGIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LADCX vs. VSGIX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LADCX is a Buy and VSGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 36.9B vs. LADCX (1.92B). VSGIX pays higher dividends than LADCX: VSGIX (0.55) vs LADCX (0.00). LADCX was incepted earlier than VSGIX: LADCX (29 years) vs VSGIX (25 years). LADCX (1.69) is less costly to investors than VSGIX (0.06). LADCX is a more actively managed with annual turnover of: 122.00 vs. VSGIX (21.00). LADCX has a lower initial minimum investment than VSGIX: LADCX (1000) vs VSGIX (5000000). LADCX (4.04) and VSGIX (3.92) have marching annual gain over last year. VSGIX return over 5 years is better than : 35.54 vs. LADCX (-27.82).
LADCXVSGIXLADCX / VSGIX
Total Expense Ratio1.690.062,817%
Annual Report Gross Expense Ratio1.690.062,817%
Fund Existence29 years25 years-
Gain YTD-2.298-0.701328%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.92B36.9B5%
Annual Yield % from dividends0.000.55-
Returns for 1 year4.043.92103%
Returns for 3 years25.3837.7367%
Returns for 5 years-27.8235.54-78%
Returns for 10 years-50.08110.20-45%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV2.380.26
+12.26%
Artiva Biotherapeutics Inc
CEP35.241.66
+4.94%
Cantor Equity Partners Inc
CR187.431.68
+0.90%
Crane Company
VCYT25.17-1.48
-5.55%
Veracyte
PHH0.95-0.06
-5.93%
Park Ha Biological Technology Co Ltd